- Academic Editor
Background: Polycystic ovary syndrome (PCOS) is commonly associated
with metabolic disorders. Abscisic acid (ABA), a plant hormone found in
vegetables and fruits that can be naturally supplied through dietary intake, has
previously been studied for its benefits to human health, particularly in people
with diabetes. ABA plays a key role in glucose metabolism, inflammation, and
tumor growth. The aim of this study was to investigate the therapeutic effect of
ABA on letrozole-induced PCOS rats. Methods: Wistar rats were implanted
with continuous-release letrozole pellets to induce a PCOS-like phenotype, and
subsequently treated with ABA or vehicle control. Body weight changes,
Testosterone (T) levels, fasting insulin measurements, and glucose tolerance
tests were investigated. A cell apoptosis model, induced by hydrogen peroxide
(H
Polycystic ovary syndrome (PCOS) is a common endocrine disorder affecting reproductive women, which is associated with reproductive and metabolic alterations, including hyperandrogenism, insulin resistance (IR), polycystic ovaries, infertility, and an increased risk of cardiovascular disease and type 2 diabetes [1]. The prevalence and incidence of metabolic syndrome are much higher in PCOS patients. Hypotheses for this pathological mechanism include genetic abnormalities, hormonal imbalances and environmental and lifestyle factors [2]. Previous studies have reported that PCOS patients who lose weight could benefit from improved ovulation [3, 4]. Currently, accessible medication for PCOS is controversial due to the complex nature of this disease.
Abscisic acid (ABA), a phytohormone widely present in fruits and vegetables at
varying concentrations, has been shown to behave as an endogenous hormone in
mammals. In healthy subjects, it is produced and released from human pancreatic
Oxidative stress might support IR in PCOS and directly stimulate the
overproduction of ovarian androgen. Accumulating researches have demonstrated
that oxidative stress induced by reactive oxygen species (ROS) may promote the
development of IR and hyperandrogenism, while inflammatory cytokine might be
associated with endothelial dysfunction, all of which are key characteristics of
PCOS [14, 15]. ROS was highly expressed in ovarian tissues of letrozole-induced
PCOS rats [16]. Pro-oxidant-antioxidant balance has a pivotal role in
folliculogenesis and oocyte maturation of the female reproductive system [14].
ABA is also released by innate immune cells upon physical or chemical
stimulation; ABA could stimulate functional activities of these cells, including
migration, phagocytosis, and release of ROS and nitric oxide (NO) by inhibiting
the nuclear factor kappa B pathway (NF-
Letrozole is believed to recapitulate both the endocrine and metabolic
phenotypes of PCOS clinically and is widely used in animal models to induce PCOS
experimentally [19]. Previously, we have successfully established a
letrozole-induced PCOS rat model with PCOS-like reproductive, endocrine, and
metabolic phenotypes [20]. An oxidative stress model of the human ovarian
granulosa cell line (KGN) induced by H
Female Wistar rats were obtained from Chengdu Dashuo Experimental Animals
Limited Company (Chengdu, Sichuan, China). All animal procedures were conducted
in accordance with ethical principles in animal research and approved by the
Animal Ethics Committee of West China Second University Hospital of Sichuan
University (No. 2018-013). Every effort was made to reduce the number of animals
in each experimental group and to ensure that discomfort and pain were kept to a
minimum. The Wistar rats were housed five per cage under standard conditions
(12:12 h of light-dark cycle; at 23
At 12 weeks of age, blood samples were obtained and stored at –20 °C. The rats
were decapitated, ovariectomized, fixed for 24 h in neutral buffered 4%
paraformaldehyde, placed in 70% ethanol, dehydrated, and embedded in paraffin.
After formalin-fixed ovaries were processed by paraffin embedding, samples were
longitudinally and serially cut into 5
All rats were weighed weekly on electronic scales during the experiment. After
ABA treatment, T level, Glucose tolerance, and fasting insulin were evaluated. T
level was determined by gas chromatography and mass spectrum (GC-MS) (Agilent
Technologies, Santa Clara, CA, USA). Fasting glucose (FPG) was measured by
ACCU-CHEK II (Roche, Basel, Switzerland) as previously mentioned after eight
hours of overnight fasting. Rats were then injected intraperitoneally with a
bolus of 1 g/kg glucose in 0.9% NaCl. Blood glucose determination was assessed
at 0, 15-, 30-, 60-, and 120 minutes post-injection. Fasting insulin (FINS) and
fasting glucose (FPG) were measured by a radioimmunoassay kit (EMD Millipore
Corporation, Billerica, MA, USA). Additionally, HOMA-IR (homeostasis model
assessment of IR) was determined by fasting insulin and glucose values, and
calculated as Fasting insulin (mIU/L)
KGN cells (Procell CL-0603) were obtained from Procell Life Science&Technology
Co., Ltd (Wuhan, Hubei, China) in 2021. The cell line had been authenticated
using short tandem repeat (STR) markers, and mycoplasma testing has been done.
KGN cells were cultured in Dulbecco’s modified eagle’s medium/nutrient mixture
F-12 (DMEM/F12) (Gibco, New York, NY, USA), supplemented with 10% fetal bovine serum
and 100 IU/mL penicillin/streptomycin. The processing time and concentration of
H
KGN cells were incubated into a 96-well plate at a concentration of 5000
cells/well. The original culture solution was drained out by flowing
H
According to the instructions of the kit, apoptosis of KGNs was detected by
Annexin V-FITC-PI double-staining assay (CK04, DOJINDO, Kumamoto, Japan).
Cultured KGNs were diluted at 5
According to the manufacturer’s instructions, the ROS level was detected by the
Fluorometric Intracellular ROS Kit (MAK145, Sigma-Aldrich, Darmstadt, Germany).
The Fluorometric Intracellular ROS Assay Kit provides a sensitive, one-step
fluorescence detection method that can detect intracellular ROS in live cells
within 1 h of incubation (especially superoxide and hydroxyl radicals). ROS
reacts with a cell-permeable sensor to produce a fluorometric measurement product
(lex = 520/LEM = 605 nm) proportional to the amount of ROS present. ROS levels
were analyzed by Flow Cytometry (FACS Calibur, American BD, Franklin Lakes, NJ,
USA) according to the manufacturer’s instructions: a primary reaction mixture of
100 µL/well (96-well plate) was added to the cell plate; cells were
cultured in a 5% CO
Data are expressed as means
The PCOS rat model was successfully induced by continuous-release letrozole pellets for 56 days and subsequently followed by ABA therapy for 14 days (Fig. 1A). Weight gain, impaired IR, and elevated T level were observed in PCOS rats, factors that were significantly reduced after ABA treatment (Fig. 1C,D,F,G). Intraperitoneal glucose tolerance test (IPGTT) for glucose tolerance showed no significant changes (Fig. 1E). In addition, H&E staining of ovaries revealed that a significant abnormal polycystic morphology and a greater number of cystic follicles were exhibited in the PCOS rat group, whereas, the number of cystic follicles was significantly smaller after ABA treatment (Fig. 1B).
Abscisic acid (ABA) treatment in Polycystic Ovary Syndrome
(PCOS) rats induced by letrozole. (A) PCOS rats were induced for 49 days by
subcutaneously implantation of 90-day continuously released letrozole pellet,
followed by 14 days of ABA treatment. (B) 1-1 and 1-2 for Control, 2-1 and 2-2
for PCOS, 3-1 and 3-2 for PCOS + ABA, alleviated the abnormal ovarian morphology
of the PCOS rats. (Scale bar = 200
The KGN cells were treated with 100
The effects of ABA on cell viability and apoptosis in
H
We next investigated whether ABA acted by reducing ROS content in
H
The effects of ABA on reactive oxygen species (ROS) levels in
H
In the present study, we made use of a well-established model of PCOS implanted
with letrozole pellets to study its effects on IR, as previously reported [20].
Our findings suggest that ABA treatment results in decreased T concentration and
body weight, as well as improvement of IR in PCOS rats induced by letrozole.
Furthermore, ABA reversed H
In the present study, PCOS rats induced by letrozole did not exhibit any
significant changes in IPGTT, but induced IR with abnormal insulin levels and
increased T levels, consistent with our previous study [19]. These phenotypes are
more similar to those of PCOS patients. Those PCOS rats also have been reported
to exhibit drastic elevation of NF-kB levels, and the overexpression of
NF-
Herein, dietary ABA was shown to alleviate PCOS throughout a range of routine
indicators, including reduced body weight, the rectification of abnormal T, and
improved IR. Our data are consistent with the above findings on promoting insulin
sensitivity. Guri et al. [10] showed that ABA treatment of glucose
metabolism regulation in obese and prediabetic mice is due to its structural
similarity to thiazolidinediones, while its efficacy is similar to those of these
anti-diabetic oral drugs. ABA may be an effective insulin-sensitizing compound,
have the ability to control systemic glycemic responses and skeletal muscle
metabolism. ABA treatment induced greater insulin sensitivity [12]. Nevertheless,
unlike thiazolidinediones, ABA exerts its hypoglycemic effect in mammals by
binding LANCL2 and acting on peroxisome proliferator-activated receptor gamma
(PPAR
Oxidative stress has been proven to be involved in follicle differentiation, proliferation and maturation, which may be closely related to the number of meiotic I oocytes [14, 24]. Oxidative stress has been associated with a number of reproductive disorders, including PCOS, Primary Ovarian Insufficiency, endometriosis, infertility, and aging. ROS production plays a vital role in inducing oocyte meiosis, higher ROS level appears to impair oocyte maturation, and oxidative stress can induce uncoordinated functions of granulosa cells, affecting oocyte quality [25, 26]. Elevated ROS in the ovarian tissues had been found in letrozole-treated PCOS rats [16].
Meanwhile, the antioxidant protective effects of ABA have been widely studied.
Rafiepour et al. [27] demonstrated that the PPAR
Our study is only a preliminary investigation of ABA in the context of the PCOS rat model and ovarian function. The possible mechanism of the effect of ABA on testosterone might be the potent phytoestrogenic property of ABA, as ABA treatment group showed remarkable improvement of ovulation and decreased abnormal cysts. Further research is needed to investigate the effects of ABA on ovary function using in vivo and in vitro studies, such as the effects on theca cell, angiogenesis, and folliculogenesis. Continued exploration could be clinically relevant for fertility in women, addressing whether ABA could be used as an intervention to treat reproductive disorders.
In conclusion, the current research uncovered a novel role of ABA in the
regulation of the metabolic and endocrine imbalance of the PCOS model,
demonstrating that ABA represses H
The datasets used and/or analyzed during the current study are available from the corresponding author on reasonable request.
All authors contributed to the study’s conception and design. YDX, JLG, YFZ, and LX performed the experiments and acquired the data. XHL and SWL participated in data analysis. YDX prepared the manuscript. LX revised the manuscript. All authors contributed to editorial changes in the manuscript. All authors read and approved the final manuscript. All authors have participated sufficiently in the work to take public responsibility for appropriate portions of the content and agreed to be accountable for all aspects of the work in ensuring that questions related to its accuracy or integrity.
All the animal procedures were performed by the ethical principle in animal research and approved by the Animal Ethics Committee of West China Second University Hospital of Sichuan University, No. 2018-013.
We would like to express our thanks to everyone who helped us in the process of writing this manuscript. Thanks to all the peer reviewers for their opinions and suggestions.
This work was supported by a grant from the Natural Science Foundation of Sichuan Province (No.2022NSFSC1372), a grant from the National Natural Science Foundation of China (No.81671422), and a grant from the National Key Research and Development Program of China (No.2016YFC100206).
The authors declare no conflict of interest.
Publisher’s Note: IMR Press stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.